tiprankstipranks
Trending News
More News >
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market

Zevra Therapeutics (ZVRA) Income Statement

Compare
876 Followers

Zevra Therapeutics Income Statement

Last quarter (Q4 2024), Zevra Therapeutics's total revenue was $12.04M, a decrease of -8.88% from the same quarter last year. In Q4, Zevra Therapeutics's net income was $-35.74M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 23.61M$ 27.46M$ 10.46M$ 28.65M$ 13.29M
Gross Profit
$ 16.20M$ 24.52M$ 10.12M$ 26.59M$ 11.98M
Operating Expenses
$ 103.20M$ 74.12M$ 34.96M$ 18.86M$ 16.76M
Depreciation and Amortization
$ 6.39M$ 1.01M$ 944.00K$ 257.00K$ 273.00K
EBITDA
$ -76.40M$ -48.60M$ -25.53M$ -7.89M$ -5.43M
Operating Income
$ -87.00M$ -49.60M$ -24.84M$ 7.73M$ -4.78M
Other Income/Expenses
$ -3.14M$ 3.56M$ -1.96M$ -16.25M$ -7.18M
Pretax Income
$ -90.14M$ -46.05M$ -42.33M$ -8.52M$ -12.79M
Net Income
$ -105.51M$ -46.05M$ -41.54M$ -8.55M$ -12.76M
Per Share Metrics
Basic EPS
$ -2.28$ -1.30$ -1.20$ -0.29$ -3.21
Diluted EPS
$ -2.28$ -1.30$ -1.20$ -0.29$ -3.21
Weighted Average Shares Outstanding
46.25M 35.45M 34.49M 29.77M 3.98M
Weighted Average Shares Outstanding (Diluted)
46.25M 35.45M 34.49M 29.77M 3.98M
Currency in USD

Zevra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis